Evidence map›Paper›PMID 41156954›Full record

ArticleMaterials (Basel, Switzerland)2025

Synergistic Effects of High-Modulus Additives on SBS-Modified Asphalt: Microstructural, Rheological Enhancement, and Dosage-Dependent Performance Optimization.

Qinghua He, Zhuosen Li, Jianqi Huang, Jie Chen, Liujun Zhao, Chengwei Xing, Tong Cui, Jiabiao Zou

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qinghua HeSchool of Highway, Chang'an University, Xi'an 710061, China.
Zhuosen LiSchool of Highway, Chang'an University, Xi'an 710061, China.
Jianqi HuangGuangzhou Expressway Co., Ltd., Guangzhou 510540, China.
Jie ChenPoly Changda Engineering Co., Ltd., Guangzhou 511431, China.
Liujun ZhaoGuangzhou Expressway Co., Ltd., Guangzhou 510540, China.
Chengwei XingSchool of Highway, Chang'an University, Xi'an 710061, China.
Tong CuiPoly Changda Engineering Co., Ltd., Guangzhou 511431, China.
Jiabiao ZouGuangzhou Expressway Co., Ltd., Guangzhou 510540, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study systematically investigates the synergistic modification effects of two high-modulus additives on SBS-modified asphalt through microstructural characterization and performance evaluation. Fluorescence microscopic analysis reveals that the additive particles undergo swelling over time and form an interconnected network structure via phase separation dynamics. Rheological tests demonstrate a significant enhancement in high-temperature performance: at the optimal dosage of 10 wt%, the complex modulus increases by approximately 215%, and the rutting factor improves by about 300% compared to the control group. The results from multiple stress creep recovery (MSCR) tests confirm the material's superior elastic recovery capability and reduced non-recoverable creep compliance. However, the incorporation of the additives adversely affects low-temperature ductility. The penetration of (two distinct high-modulus agents, designated as HMA-A and HMA-B) HMA-B decreases by approximately 36.8% more than that of HMA-A, accompanied by significantly lower low-temperature toughness. A dosage of 10% is identified as the critical threshold, which maximizes rutting resistance while minimizing low-temperature performance degradation. Based on these findings, this paper proposes an integrated design paradigm of "microstructure-performance-dosage," recommending HMA-B for high-stress pavement channels and HMA-A for regions with substantial temperature variations.

Indexed as

composite modificationhigh-modulus asphalthigh-temperature performanceSBS-modified asphaltthreshold

Identifiers

PMID41156954
PMCPMC12565973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.